PFBT
MIRM icon

Parkside Financial Bank & Trust’s Mirum Pharmaceuticals MIRM Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75K Hold
15
– – ﹤0.01% 2225
2026
Q1 		$1.39K Hold
15
– – ﹤0.01% 2236
2025
Q4 		$1.19K Hold
15
– – ﹤0.01% 2281
2025
Q3 		$1.1K Hold
15
– – ﹤0.01% 2245
2025
Q2 		$764 Hold
15
– – ﹤0.01% 2352
2025
Q1 		$676 Buy
+15
New +$707 ﹤0.01% 2230

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parkside Financial Bank & Trust's MIRM Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 15 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2225.

Parkside Financial Bank & Trust first reported a position in MIRM in Q1 2025 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Parkside Financial Bank & Trust held 15 shares of Mirum Pharmaceuticals worth $1.75K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2225 holding.
  • Parkside Financial Bank & Trust first reported a position in Mirum Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.